This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

First IMRIS Intraoperative Suite In Canada Featuring Flexibility Of MRI And Angiography Opens At Health Sciences Centre Winnipeg

Neurosurgeons can image, treat patients within three-room suite without moving patients

WINNIPEG, Sept. 17, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company") today announced the official opening of the first VISIUS ® Surgical Theatre in Canada that features both intraoperative MRI (iMRI) and angiography capability together in a three-room suite at Health Sciences Centre Winnipeg.

"As Manitoba's center for trauma and neurosciences, the IMRIS suite enhances our surgical and diagnostic expertise and gives us an important technology platform that is an integral part of emerging therapies and procedures that advance patient care," said Dr. Neil Berrington, Head of Neurosurgery at HSC Winnipeg. "It's a powerful part of the Centre for Surgical Innovation in our new Kleysen Institute for Advanced Medicine and raises the bar in bringing together neurosurgical research and improved patient outcomes."

The VISIUS Surgical Theatre features an MR scanner and an interventional bi-plane angiography system. Mounted on ceiling rails for on-demand movement, the MR scanner can be deployed into any of three rooms - permitting rapid and efficient transitions between MR imaging and surgery or intervention without transporting the patient between modalities.

MR images can be taken before and during procedures to assess tissue condition, and can also be used in conjunction with fluoroscopic images during neurovascular procedures. When not in use for intraoperative imaging, both the MR and fluoroscopic system are available for diagnostic use as well.

The largest hospital in Winnipeg, HSC Winnipeg is the fourth Canadian institution to install a VISIUS Surgical Theatre and one of five in North America with a combined iMRI and angiography suite, providing multi-modality image guidance capabilities to assist clinicians in improving outcomes for patients during neurosurgical and interventional procedures. The angiography capability will assist surgeons with neurovascular procedures such as stroke management.

IMRIS CEO Jay D. Miller said this is a big step for healthcare in Manitoba and Canada. "The combined benefits of the IMRIS solution will assist in addressing a broad range of neurological disorders. As a company founded in Winnipeg, Manitoba, we are delighted that our solutions will be contributing to proven reductions in re-operation rates," he said.


IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image guided therapy solutions through its VISIUS Surgical Theatre - a revolutionary, multifunctional surgical environment that provides unmatched intraoperative vision to clinicians to assist in decision making and enhance precision in treatment. The multi-room suites incorporate diagnostic quality high-field MR, CT and angio modalities accessed effortlessly in the operating room setting. VISIUS Surgical Theatres serve the neurosurgical, spinal, cardiovascular and cerebrovascular markets and have been selected by 54 leading medical institutions around the world.


1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,893.98 -18.31 -0.11%
S&P 500 1,995.83 +15.91 0.80%
NASDAQ 4,742.9810 -48.1710 -1.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs